GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its fourth quarter and full year 2023 financial results after market close on Thursday, February 29, 2024.
Management will hold a conference call to review the Company’s fourth quarter and full year 2023 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International), passcode 3711982, approximately ten to five minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics’ CGM system Eversense® E3 includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user’s smartphone.
Contacts
Investor Contact
Philip Taylor
Gilmartin Group
415-937-5406
Investors@senseonics.com
SAN DIEGO, CA / ACCESSWIRE / June 11, 2024 / For those afflicted by substance…
Between Us Clinic Survey Reveals Urologists' Top ED Treatment Recommendations: Diet, Exercise, and Mindfulness Meditation…
Company earns recertification, validating commitment to strong cybersecurity protecting sensitive dataBALTIMORE--(BUSINESS WIRE)--Real Time Medical Systems…
Annual User Conference and Innovation Challenge Designed to Pioneer the Future of Digital Health and…
Company earns recertification, validating commitment to strong cybersecurity protecting sensitive dataBALTIMORE--(BUSINESS WIRE)--Real Time Medical Systems…
Annual User Conference and Innovation Challenge Designed to Pioneer the Future of Digital Health and…